Lexicon Pharmaceuticals
LXRX
#6215
Rank
HK$8.08 B
Marketcap
HK$18.19
Share price
-0.85%
Change (1 day)
151.92%
Change (1 year)

Lexicon Pharmaceuticals (LXRX) Fails to deliver data

Key failure to deliver metrics for Lexicon Pharmaceuticals :

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Lexicon Pharmaceuticals (LXRX) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Lexicon Pharmaceuticals (LXRX) - since 2015

Volume in USD (price x number of shares), data since 2015

Lexicon Pharmaceuticals (LXRX) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2026HK$0.47 M-96.17%
2025HK$12.43 M-38.43%
2024HK$20.19 M111.04%
2023HK$9.57 M315.88%
2022HK$2.3 M-91.22%
2021HK$26.2 M1.63%
2020HK$25.78 M21.18%
2019HK$21.27 M-6.95%
2018HK$22.86 M-27.5%
2017HK$31.53 M18.35%
2016HK$26.64 M59.83%
2015HK$16.67 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Thermo Fisher Scientific
TMO
HK$37.9 MHK$92.26 M๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
HK$18.88 MHK$37.8 M๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
HK$2.01 MHK$23.39 M๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
HK$5.46 MHK$13.53 M๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
HK$3.37 MHK$13.15 M๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
HK$15.87 MHK$23.01 M๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
N/AHK$0.94 M๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
HK$4.67 MHK$14.82 M๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
HK$0.01 MHK$4.79 M๐Ÿ‡บ๐Ÿ‡ธ USA